You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adoptive T cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cytomegalovirus Infections, Hematopoietic Stem Cell Transplant, Opportunistic Infections Trial in Cleveland (CMV specific

Recruiting
  • Cytomegalovirus Infections
  • +2 more
  • CMV specific adoptive t-cells
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 26, 2022

Advanced Hepatocellular Carcinoma Trial in Zhuhai (GDKM-100 injection)

Withdrawn
  • Advanced Hepatocellular Carcinoma
  • GDKM-100 injection
  • Zhuhai, Guangdong, China
    Zhuhai People'S Hospital
Jan 16, 2023

Hepatocellular Carcinoma Trial in Beijing (iNKT Cells, PD-1, Regorafenib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • iNKT Cells
  • +2 more
  • Beijing, Beijing, China
    Beijing Youan Hospital,Capital Medical University
Jul 24, 2023

Progressive Multifocal Leukoencephalopathy Trial run by the National Institute of Neurological Disorders and Stroke (NINDS)

Completed
  • Progressive Multifocal Leukoencephalopathy
  • PyVST
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Prostate Cancer Trial in New York (engineered autologous T cells, cyclophosphamide)

Active, not recruiting
  • Prostate Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 28, 2022

Peripheral Blood Mononuclear Cells From Healthy People for

Recruiting
  • Healthy Volunteer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 20, 2022

    SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19

    Recruiting
    • COVID-19
    • Blood donation from convalescent donor
    • Singapore, Singapore
    • +1 more
    Mar 29, 2022

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Phoenix (Autologous MUC1-activated T-cells,

    Recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Phoenix, Arizona
      Mayo Clinic Hospital in Arizona
    Jan 4, 2023

    Haematological Malignancies Trial in London, Manchester (CD25/71 allodepleted donor T-cells)

    Completed
    • Haematological Malignancies
    • CD25/71 allodepleted donor T-cells
    • London, United Kingdom
    • +1 more
    Jul 18, 2022

    HNSCC, Melanoma, Gynecologic Cancer Trial in Portland (DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2)

    Recruiting
    • HNSCC
    • +5 more
    • DP CD8 TIL
    • +2 more
    • Portland, Oregon
      Providence Portland Medical Center
    Jun 5, 2023

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Philadelphia (MOv19-BBz CAR T cells, Alpha Folate

    Recruiting
    • Ovarian Cancer
    • +2 more
    • MOv19-BBz CAR T cells
    • Alpha Folate Receptor expression test
    • Philadelphia, Pennsylvania
      University of Pennsylvania Health System
    Sep 12, 2022

    Melanoma, Melanoma, Uveal, Head Neck Cancer Trial in Rotterdam (Adoptive therapy with autologous MC2 TCR T cells)

    Recruiting
    • Melanoma
    • +2 more
    • Adoptive therapy with autologous MC2 TCR T cells
    • Rotterdam, Netherlands
      Erasmus Medical Center
    Jun 1, 2022

    CD 19+ Acute Leukemia Trial in Seattle (T-cell Antigen Presenting Cells expressing truncated CD19 (T-APC))

    Active, not recruiting
    • CD 19+ Acute Leukemia
    • T-cell Antigen Presenting Cells expressing truncated CD19 (T-APC)
    • Seattle, Washington
      Seattle Children's Hospital
    Mar 22, 2022

    Leukemia, Lymphoma Trial in United States (SCRI-CAR22v2)

    Recruiting
    • Leukemia
    • Lymphoma
    • SCRI-CAR22v2
    • Los Angeles, California
    • +4 more
    Jan 18, 2023

    Synovial Sarcoma Trial in Houston (Fludarabine phosphate, NY-ESO-1 TCR/IL-15 NK, Cyclophosphamide)

    Not yet recruiting
    • Synovial Sarcoma
    • Fludarabine phosphate
    • +2 more
    • Houston, Texas
      MD Anderson Cancer Center
    Oct 9, 2023

    Viral Infection After HSCT Trial (Virus -specific T cells)

    Not yet recruiting
    • Viral Infection After HSCT
    • Virus -specific T cells
    • (no location specified)
    Mar 28, 2022

    HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T

    Not yet recruiting
    • HPV-Associated Cervical Carcinoma
    • +16 more
    • Conditioning, E7 TCR-T cells, and aldesleukin
    • New Brunswick, New Jersey
      Rutgers Cancer Institute of New Jersey
    Jan 17, 2023

    Metastatic Breast Cancer Trial in Duarte (huMNC2-CAR44 CAR T cells, huMNC2-CAR44 CAR T cells @ RP2D)

    Recruiting
    • Metastatic Breast Cancer
    • huMNC2-CAR44 CAR T cells
    • huMNC2-CAR44 CAR T cells @ RP2D
    • Duarte, California
      City of Hope Medical Center
    Dec 22, 2021

    CMV Infection After Allogenic HSCT Trial in Beijing (CMV-TCR-T cells)

    Recruiting
    • CMV Infection After Allogenic HSCT
    • CMV-TCR-T cells
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Dec 5, 2021

    Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 Trial in Seattle (drug, other, biological, radiation)

    Terminated
    Has Results
    • Merkel Cell Polyomavirus Infection
    • Stage IV Merkel Cell Carcinoma AJCC v7
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Feb 25, 2022

    Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+

    Active, not recruiting
    • Metastatic Malignant Neoplasm in the Liver
    • Metastatic Uveal Melanoma
    • Aldesleukin
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 20, 2023

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (biological, drug, procedure)

    Completed
    Has Results
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 3, 2022

    Serologically Active Adult Systemic Lupus Erythematosus Trial in Nantes, Paris (Autologous EBV specific CTL infusion)

    Terminated
    • Serologically Active Adult Systemic Lupus Erythematosus
    • Autologous EBV specific CTL infusion
    • Nantes, France
    • +2 more
    Mar 24, 2022

    B Cell Leukemia Trial in Seattle (Autologous CD19 CAR+ EGFTt + T cells)

    Active, not recruiting
    • B Cell Leukemia
    • Autologous CD19 CAR+ EGFTt + T cells
    • Seattle, Washington
      Seattle Children's Hospital
    Feb 15, 2022

    COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

    Active, not recruiting
    • COL6A3 Positive
    • +3 more
    • Aldesleukin
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2022